BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25180154)

  • 1. High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure.
    Smith MB; Griffiths EA; Thompson JE; Wang ES; Wetzler M; Freyer CW
    Leuk Res Rep; 2014; 3(2):62-6. PubMed ID: 25180154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudotumour cerebri in acute promyelocytic leukemia on treatment with all-trans-retinoic acid (ATRA) - an experience from a tertiary care centre.
    Ahmad Tali M; Bashir Y; Bhat S; Manzoor F; Bashir N; Geelani S; Rasool J; Waheed Mir A
    Malays J Pathol; 2015 Aug; 37(2):141-4. PubMed ID: 26277671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
    Zhu HH; Wu DP; Du X; Zhang X; Liu L; Ma J; Shao ZH; Ren HY; Hu JD; Xu KL; Wang JW; Song YP; Fang MY; Li J; Yan XY; Huang XJ
    Lancet Oncol; 2018 Jul; 19(7):871-879. PubMed ID: 29884593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
    Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudotumor cerebri in a patient with acute promyelocytic leukemia during treatment with all-trans retinoic acid.
    Sano F; Tsuji K; Kunika N; Takeuchi T; Oyama K; Hasegawa S; Koike M; Takahashi M; Ishida M
    Intern Med; 1998 Jun; 37(6):546-9. PubMed ID: 9678691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic Criteria.
    Coombs CC; DeAngelis LM; Feusner JH; Rowe JM; Tallman MS
    Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):146-51. PubMed ID: 26724834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudotumor cerebri due to the potentiation of all-trans retinoic acid by voriconazole.
    Dixon KS; Hassoun A
    J Am Pharm Assoc (2003); 2010; 50(6):742-4. PubMed ID: 21071321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.
    Zhang X; Zhang H; Chen L; Wang M; Xi J; Liu X; Xie M; Li D; Gulati ES; Gong S; Wang H
    Trials; 2018 Sep; 19(1):476. PubMed ID: 30185214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-Trans Retinoic Acid-Induced Pseudotumor Cerebri during Induction Therapy for Acute Promyelocytic Leukemia: A Case Report and Literature Review.
    Holmes D; Vishnu P; Dorer RK; Aboulafia DM
    Case Rep Oncol Med; 2012; 2012():313057. PubMed ID: 22701192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
    Lo-Coco F; Avvisati G; Vignetti M; Thiede C; Orlando SM; Iacobelli S; Ferrara F; Fazi P; Cicconi L; Di Bona E; Specchia G; Sica S; Divona M; Levis A; Fiedler W; Cerqui E; Breccia M; Fioritoni G; Salih HR; Cazzola M; Melillo L; Carella AM; Brandts CH; Morra E; von Lilienfeld-Toal M; Hertenstein B; Wattad M; Lübbert M; Hänel M; Schmitz N; Link H; Kropp MG; Rambaldi A; La Nasa G; Luppi M; Ciceri F; Finizio O; Venditti A; Fabbiano F; Döhner K; Sauer M; Ganser A; Amadori S; Mandelli F; Döhner H; Ehninger G; Schlenk RF; Platzbecker U; ; ;
    N Engl J Med; 2013 Jul; 369(2):111-21. PubMed ID: 23841729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
    Nagao R; Hosoba R; Yahagi Y; Gunji T; Uryu H; Hattori D; Momoki M; Yamazaki H
    Rinsho Ketsueki; 2019; 60(10):1431-1435. PubMed ID: 31695003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudotumor cerebri caused by all-trans-retinoic acid: a case report.
    Tiamkao S; Sirijirachai C
    J Med Assoc Thai; 2000 Nov; 83(11):1420-3. PubMed ID: 11215876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
    Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-trans-retinoic acid-induced pseudotumor cerebri in acute promyelocytic leukemia.
    Anoop TM; Jain N; Nair SG; Narayanan G
    J Neurosci Rural Pract; 2014 Jul; 5(3):273-5. PubMed ID: 25002770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial.
    Zhang L; Zou Y; Chen Y; Guo Y; Yang W; Chen X; Wang S; Liu X; Ruan M; Zhang J; Liu T; Liu F; Qi B; An W; Ren Y; Chang L; Zhu X
    BMC Cancer; 2018 Apr; 18(1):374. PubMed ID: 29615003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.
    Iriyama N; Yuan B; Hatta Y; Horikoshi A; Yoshino Y; Toyoda H; Aizawa S; Takeuchi J
    Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combination of all-trans retinoic acid and arsenic trioxide on apoptosis of acute promyelocytic leukemia cells.
    Hu J; Sun Q; Fang W; Wang Q
    Cell Mol Biol (Noisy-le-grand); 2019 Apr; 65(4):97-100. PubMed ID: 31078158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.
    Ghavamzadeh A; Jalili M; Rostami S; Yaghmaie M; Aliabadi LS; Mousavi SA; Vaezi M; Fumani HK; Jahani M; Alimoghaddam K
    Leuk Res; 2018 Mar; 66():85-88. PubMed ID: 29407588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: a possible disease association.
    Visani G; Bontempo G; Manfroi S; Pazzaglia A; D'Alessandro R; Tura S
    Haematologica; 1996; 81(2):152-4. PubMed ID: 8641645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudotumor cerebri presenting with visual failure in promyelocytic leukemia: a case report.
    Rasul FT; Toma AK; Khan AA; Plant GT; Watkins LD
    J Med Case Rep; 2012 Nov; 6():408. PubMed ID: 23194090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.